|
Market Closed -
Canadian Securities Exchange
15:55:43 2026-10-16 EDT
|
5-day change | 1st Jan Change | ||
| 0.5300 CAD | -3.64% |
|
-1.85% | -24.29% |
| Market Cap | 96.83M 86.15M 79.75M 72.65M 137M 9.19B 139M 958M 376M 4.79B 363M 356M 15.3B | P/E 2024 |
-12x | P/E 2025 | 71.9x |
|---|---|---|---|---|---|
| Enterprise Value | 112M 99.76M 92.35M 84.13M 159M 10.65B 161M 1.11B 436M 5.55B 421M 412M 17.71B | EV / Sales 2024 |
5.45x | EV / Sales 2025 | 4.4x |
| Free-Float |
61.83% | Yield 2024 * |
-
| Yield 2025 | - |
Canadian Securities ExchangeCAD
| Markets | Quality | ||
|---|---|---|---|
Canadian Securities Exchange
| GRIN | Delayed | |
OTC Markets
| GRUSF | Delayed | |
|
Deutsche Boerse AG
| 1VF0 | Delayed |
Last Transcript: Grown Rogue International Inc.
| 1 day | -3.64% | ||
| 1 week | -1.85% | ||
| Current month | -10.17% | ||
| 1 month | -11.67% | ||
| 3 months | -20.90% | ||
| 6 months | +17.78% | ||
| Current year | -24.29% |
| 1 week | 0.52 |  | 0.59 |
| 1 month | 0.52 | | 0.66 |
| Current year | 0.38 | | 0.72 |
| 1 year | 0.38 | | 0.72 |
| 3 years | 0.32 | | 1.15 |
| 5 years | 0.06 | | 1.15 |
| 10 years | 0.06 | | 1.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Strickler
CEO | Chief Executive Officer | 45 | 2018-11-14 |
Sarah Strickler
PRN | Corporate Officer/Principal | - | 2016-09-30 |
| Director of Finance/CFO | 42 | 2024-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Gledhill
BRD | Director/Board Member | 64 | 2018-11-14 |
J. Strickler
CHM | Chairman | 45 | - |
Ryan Kee
BRD | Director/Board Member | 42 | 2024-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/21/26 | Option | Director | 120,000 | 0.0480% | ||
| 7/21/26 | Option | Director | 120,000 | 0.0480% | ||
| 7/21/26 | Free | Founder | 1,000,000 | 0.4001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.64% | -1.85% | -8.62% | +47.22% | 96.83M | |
| +0.43% | +7.48% | +52.08% | +106.34% | 1,116B | |
| +0.90% | -0.36% | +33.68% | +62.93% | 610B | |
| +0.71% | +4.77% | +26.17% | +92.90% | 501B | |
| +0.52% | +2.51% | +73.52% | +40.32% | 358B | |
| -0.13% | +7.51% | +33.47% | +48.68% | 366B | |
| -0.95% | +5.93% | +19.86% | +42.48% | 288B | |
| -1.98% | +4.66% | -1.57% | +13.41% | 261B | |
| -0.35% | +6.15% | +45.46% | +52.23% | 235B | |
| -0.75% | +6.18% | +32.03% | +101.15% | 195B | |
| Average | -0.60% | +4.92% | +30.61% | +60.77% | 392.99B | |
| Weighted average by Cap. | -0.17% | +4.93% | +38.82% | +72.16% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 27.02M 24.04M 22.25M 20.27M 38.19M 2.57B 38.91M 267M 105M 1.34B 101M 99.22M 4.27B | 32.43M 28.85M 26.71M 24.33M 45.84M 3.08B 46.7M 321M 126M 1.61B 122M 119M 5.12B |
| Net income | -11.3M -10.06M -9.31M -8.48M -15.98M -1.07B -16.28M -112M -43.92M -560M -42.42M -41.51M -1.79B | 1.73M 1.54M 1.42M 1.3M 2.45M 164M 2.49M 17.12M 6.72M 85.64M 6.49M 6.35M 273M |
| Net Debt | 3.7M 3.3M 3.05M 2.78M 5.24M 352M 5.33M 36.66M 14.39M 183M 13.9M 13.6M 585M | 15.3M 13.61M 12.6M 11.48M 21.63M 1.45B 22.03M 151M 59.44M 757M 57.41M 56.19M 2.42B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-16 | $0.5300 | -3.64% | 15,406 |
| 26-10-15 | $0.5500 | -3.51% | 29,500 |
| 26-10-14 | $0.5700 | +1.79% | 23,092 |
| 26-10-13 | $0.5600 | -1.75% | 14,000 |
| 26-10-09 | $0.5700 | +5.56% | 7,000 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- GRIN Stock
Select your edition
All financial news and data tailored to specific country editions
